1Transcriptomic study on the potential biological mechanism of peptide deacetylase in cervical cancerZHANG Lu, LIU Yiping, HAO Cuipei, LI BinARTICLES1041-10462Clinical significance of inflammatory burden index in predicting prognosis of patients with mixed hepatocellular carcinoma and cholangiocarcinomaWEI Xiaoshuang, CHEN XinhaoARTICLES1047-10513A nomogram model of recurrence survival after radical resection of stage T2-T4 lung adenocarcinomaFU Jingliang, DU Xiangkun, HE RongqiARTICLES1052-10574Clinical significance of inflammatory prognosis score in predicting the efficacy of neoadjuvant chemoradiotherapy for locally advanced rectal cancerYANG Yang, YANG Wentao, YU Xiaolan, HE LilinARTICLES1058-10635Salivary p53 autoantibody in patients with oral squamous cell carcinoma and its clinical significanceZHANG Yutao, ZHANG Lianzhi, ZHAO HongboARTICLES1064-10686Significance of inflammation index in predicting radiation pneumonia induced by radical radiotherapy in patients with locally advanced non-small cell lung cancerZHANG Liang, GAO Zhen, XUAN TingtingARTICLES1069-10737Relationship between serum sB7-H3 and treatment response and prognosis of patients with non-musculoinvasive bladder cancer after TUBRT intravesical injection of BCG vaccineZHANG Chengbo, LIU Jiajie, WANG Yijin, LIU GuoluARTICLES1074-10798Expression and clinical significance of LINC00623 in colorectal cancerZHEN Ye, YANG Jiale, ZHANG FengguoARTICLES1080-10839Expression and clinical significance of TNNT3 in patients with acute myeloid leukemiaA Ziguli, HUANG Zhihui, GU Zailinur, ZHAO Jialin, SONG Jingwen, MAO MinARTICLES1084-108810Expression and clinical significance of fibroblast growth factor receptor 2 in intrahepatic cholangiocarcinomaSHEN Jianjun, HAN Huijuan, ZHANG Lina, WANG Zengyue, WANG FengchunARTICLES1089-109411Expression and clinical significance of PKD1 and PKD2 in colorectal cancerYANG Zhen, SONG Jinli, HU BoARTICLES1095-109912Clinicopathological analysis of primary and metastatic mucinous ovarian adenocarcinomaHU Xiaodi, GAN Weijun, ZHANG Jing, WANG Keyang, WANG TongARTICLES1100-110413Clinical characteristics of immunorelated encephalitis caused by programmed death receptor-1 inhibitors:A report of 7 casesMENG Chao, LIN Li, ZHANG Tingting, LI Li, LIANG JunCLINICAL PRACTICE1105-110814Recent advances and prospects of immune checkpoint inhibitors for biliary tract cancerWANG Ying, LIU Bo, LI Dan, LI Yu, WANG Shibo, WANG NanyaREVIEWS AND LECTURES1109-111315The role of E2F transcription factor family in gastrointestinal malignant tumorsYANG Shuai, YAN Wenxian, ZHU Chao, ZHAO Wenfei, FENG Qingqing, ZHAO Wenwen, WEI HongmeiREVIEWS AND LECTURES1114-112016Progress in the application of NK cell immunotherapy in ovarian cancerCHEN Qingyu, ZHANG Jie, ZHOU Meixiang, MIN DaliuREVIEWS AND LECTURES1121-112517Progress in diagnosis and treatment of mucinous breast cancerWANG Yixuan, LIU Baorui, XIE LiREVIEWS AND LECTURES1126-113018Research progress on the application of monoclonal antibodies and antibody-drug conjugates in relapsed and refractory myelomaHU Yaofang, CHEN Xiaoqin, WANG Yun, XIA ZhongjunREVIEWS AND LECTURES1131-1136 